Compare

Spirax Group/£SPX

1D1W1M3M6MYTD1Y5YMAX

About Spirax Group

Spirax-Sarco Engineering plc, now known as Spirax Group plc, is a UK-based company providing thermal energy management and fluid technology solutions. The company operates globally in multiple sectors including steam thermal solutions, electric thermal solutions, and fluid path technologies. Founded in 1888, Spirax-Sarco Engineering has developed a significant footprint in its field, emphasizing innovation in energy management and sustainability.
Ticker
£SPX
Primary listing
LSE
Employees
10,000

Spirax Group Metrics

BasicAdvanced
£5.4B
27.14
£2.68
1.14
£1.70
2.33%

What the Analysts think about Spirax Group

Analyst ratings (Buy, Hold, Sell) for Spirax Group stock.
Analyst projections of the future price of Spirax Group stock.

Bulls say / Bears say

First-half organic revenue rose 5% and adjusted operating profit rose 8%, ahead of subdued industrial production. The adjusted margin improved to 19.8% and adjusted earnings per share increased 9%, showing that growth is translating into stronger profitability. (Investegate)
Electric Thermal Solutions grew sales by 11% in the first half, with its margin up 220 basis points as semiconductor demand, a stronger sales mix and operational improvements supported results. This gives Spirax exposure to electrification and other growing thermal applications. (Edison Group)
Watson-Marlow sales grew 7%, and biopharma orders exceeded sales, reaching their highest quarterly level since the COVID-related peak. If those orders convert into sales, they provide support for continued growth in a specialist market. (Investegate)
Steam Thermal Solutions accounts for about half of group revenue but grew sales by only 1% in the first half; adjusted profit fell 6% and its margin declined 170 basis points. Weakness in this large division could hold back group growth and profitability if the expected second-half recovery does not arrive. (Edison Group)
Cash conversion fell to 54% from 61%, while net debt reached 1.6 times EBITDA, above Spirax’s 1.0–1.5 times target range. Management expects a second-half cash recovery, but planned inventory builds and higher receivables make that an important execution test. (Edison Group)
The first-half update left full-year guidance unchanged, and Spirax shares fell after results that analysts described as broadly in line; Stifel also viewed the valuation as high. That leaves the shares exposed if second-half delivery does not meet investor expectations. (MarketScreener)
Data summarised monthly by Lightyear AI. Last updated on 4 Oct 2026.

Spirax Group Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Spirax Group Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by London Stock Exchange, through Infront.